Evolution of Insomnia During the First Year in Patients Newly Diagnosed With Cancer: a Longitudinal Study and Analysis of Associated Factors.

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

The diagnosis of cancer can be a major trigger for new sleep problems, especially insomnia, in people who did not have sleep issues before. Insomnia may appear early in the care pathway and can continue over time, often interacting with other physical or emotional symptoms. The main goal of this preliminary study is to describe how insomnia develops during the first months after a cancer diagnosis in patients who had no sleep problems at the time of diagnosis. This will be done through regular follow-up over time. A secondary aim is to identify the factors that may contribute to the onset or persistence of insomnia, such as the cancer treatments patients receive, as well as any medical or non-medical therapies used to manage sleep difficulties. The study will also look at whether patients who develop sleep problems are referred to psychologists trained in specific therapies for insomnia, and how well they follow and adhere to these treatments.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 80
Healthy Volunteers: f
View:

• Confirmed diagnosis of metastatic or non-metastatic cancer,

• Cancer treated with intravenous chemotherapy and/or immunotherapy administered intravenously or subcutaneously,

• Age ≥ 18 years,

• Ability to read and understand French,

• Patient covered by a social security system,

• Signed informed consent.

Locations
Other Locations
France
12 boulevard du Dr Chantemesse
RECRUITING
Le Puy-en-velay
Contact Information
Primary
Emilie GADEA, PhD
science.writer@ch-lepuy.fr
+33 471 043 538
Time Frame
Start Date: 2025-12-16
Estimated Completion Date: 2028-11-01
Participants
Target number of participants: 260
Treatments
Patients who have just been diagnosed with cancer.
These patients will be followed up with for one year.
Related Therapeutic Areas
Sponsors
Leads: Centre Hospitalier Emile Roux

This content was sourced from clinicaltrials.gov